We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Safety and Efficacy Study of a Single or Double Dose of HEPLISAV™ Hepatitis B Vaccine in Adults With End-Stage Renal Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00498212
Recruitment Status : Terminated (Voluntary halt due to an FDA Clinical Hold issued in relation to DV2-HBV-10.)
First Posted : July 9, 2007
Last Update Posted : February 22, 2018
Information provided by (Responsible Party):
Dynavax Technologies Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : August 2008
  Study Completion Date : October 2008
  Certification or Request for Extension to Delay Results Submission: June 16, 2014